Profitability
Weight: 25%
D-
30
- 5yr Avg ROIC -5.4%
- Operating Margin Trend +11.61 pp/yr
CSTL
Castle Biosciences, Inc.
AlphaQuality composite grade, weighted for platform & compounding fcf businesses.
⚠ 4 of the last 5 fiscal years showed negative net income — AlphaQuality will not grade above F for persistent unprofitability in a platform & compounding fcf business.
Grade overrides the 30.0 pillar composite — hard gates always win.
Capital Efficiency
Weight: 15%
F
5
- 5yr Avg ROE -6.9%
- 5yr Share-Count CAGR 3.6%
Growth Quality
Weight: 25%
B
72
- 5yr Revenue CAGR 38.3%
- 5yr EPS CAGR 0.0%
- Revenue-Growth Years (5) 5/5
Cash Generation
Weight: 20%
D
36
- 5yr FCF Margin -9.6%
- 5yr FCF/NI Conversion 2.00x
Balance Sheet
Weight: 10%
B
70
- Net Debt / EBITDA -23.15x
- Interest Coverage (EBIT/Int) -342.19x
- Altman Z-Score 4.82
Stability
Weight: 5%
B+
77
- EPS Volatility (σ/μ) 0.00
- Piotroski F-Score 2
- Negative-Revenue Years (5) 0/5
Guru Flow
Curated superinvestor sentiment — not part of the AlphaQuality grade.1 of 2 gurus held; 1 added; 1 full exit.
- Holders
- 1 -1
- Avg Δ position
- +32.7%
- New buys
- 0
- Full exits
- 1